Quick Answer
Citius Pharmaceuticals, Inc. reported Net Income of -$32.54 million for fiscal year 2023.
Citius Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2023 | -$32.54M | +3.3% |
| 2022 | -$33.64M | -45.9% |
| 2021 | -$23.05M | -31.4% |
| 2020 | -$17.55M | -12.8% |
| 2019 | -$15.56M | -24.1% |
| 2018 | -$12.54M | -20.7% |
| 2017 | -$10.38M | -25.2% |
| 2016 | -$8.30M | -185.8% |
| 2015 | -$2.90M | -293.4% |
| 2014 | -$737.7K | +42.7% |
| 2013 | -$1.29M | -4006.0% |
| 2013 | -$31.4K | -42.5% |
| 2012 | -$22.0K | +16.5% |
| 2011 | -$26.3K | -69.9% |
| 2010 | -$15.5K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$11.51M | -34.7% | -12.0% |
| December 31, 2024 | -$10.28M | -211.4% | +2.8% |
| June 30, 2024 | -$10.57M | -24.7% | -23.7% |
| March 31, 2024 | -$8.54M | +18.8% | -192.6% |
| December 31, 2023 | $9.23M | +356.9% | +208.9% |
| June 30, 2023 | -$8.48M | +4.3% | +19.4% |
| March 31, 2023 | -$10.53M | -39.2% | -192.9% |
| December 31, 2022 | -$3.59M | +61.0% | +59.5% |
- Citius Pharmaceuticals, Inc. showed an increase of +3.3% in Net Income compared to the prior fiscal year.
- Over the 2010–2023 period, Citius Pharmaceuticals, Inc.’s net income has declined by 209854.3% (from -$15.5 thousand to -$32.54 million).
- The most recent figure is from Citius Pharmaceuticals, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on December 29, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: